Posts Tagged ‘drug

April 26, 2021
Our Take: Insurers continue to reap profits, announce acquisitions in Q1
Read More
April 19, 2021
Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots
Read More
April 12, 2021
Our Take: Charity care spending at nonprofit hospitals falls short in new study
Read More
April 05, 2021
Our Take: Roundup of the latest COVID-19 vaccine news
Read More
March 29, 2021
Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates
Read More
March 22, 2021
Our Take: Amazon Care takes a potentially giant step forward
Read More
March 15, 2021
Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment
Read More
March 08, 2021
Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication
Read More
March 01, 2021
Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates
Read More
February 22, 2021
Our Take: 14 health systems come together to create health data startup Truveta
Read More
February 15, 2021
Our Take: DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law
Read More
February 08, 2021
Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4
Read More
February 01, 2021
Our Take: Leading drugmakers persist in the battle against COVID-19
Read More
January 25, 2021
Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘drug

Our Take: Insurers continue to reap profits, announce acquisitions in Q1

Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots

Our Take: Charity care spending at nonprofit hospitals falls short in new study

Our Take: Roundup of the latest COVID-19 vaccine news

Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates

Our Take: Amazon Care takes a potentially giant step forward

Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment

Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication

Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates

Our Take: 14 health systems come together to create health data startup Truveta

Our Take: DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law

Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4

Our Take: Leading drugmakers persist in the battle against COVID-19

Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘drug

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives